62.50
+1.00
+(1.63%)
At close: January 10 at 9:48:47 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 4 | 4 |
| Avg. Estimate | 0 | 0 | -0.3 | 0.41 |
| Low Estimate | 0 | 0 | -0.42 | 0.11 |
| High Estimate | 0 | 0 | -0.01 | 0.71 |
| Year Ago EPS | -- | -- | 5.43 | -0.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | 2 | 9 | 9 |
| Avg. Estimate | -- | 19M | 59.93M | 90.11M |
| Low Estimate | -- | 18M | 55.5M | 40.2M |
| High Estimate | -- | 20M | 61.8M | 116.74M |
| Year Ago Sales | -- | -- | 77.7M | 59.93M |
| Sales Growth (year/est) | -- | -- | -22.86% | 50.36% |
Earnings History
| Currency in EUR | 6/30/2024 |
|---|---|
| EPS Est. | -0.29 |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.3 | 0.41 |
| 7 Days Ago | 0 | 0 | -0.3 | 0.34 |
| 30 Days Ago | 0 | 0 | -0.4 | 0.34 |
| 60 Days Ago | 0 | 0 | -0.4 | 0.34 |
| 90 Days Ago | 0 | 0 | -0.83 | 0.65 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FYB.F | -- | -- | -105.48% | 236.97% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
8QQ.HM AbCellera Biologics Inc
2.8490
-1.79%
2160.T GNI Group Ltd.
3,085.00
-0.32%
MARI.VI Marinomed Biotech AG
14.70
+0.68%
W1H.F Onco-Innovations Limited
0.8220
-4.08%
4BB.L 4basebio PLC
1,250.00
0.00%
8QQ.F AbCellera Biologics Inc.
2.9000
+4.58%
SPHDF Santhera Pharmaceuticals Holding AG
9.42
0.00%
PI3.F Gubra A/S
86.60
-3.56%
ABVX.PA ABIVAX Société Anonyme
6.47
+2.21%
0QF.F Moderna, Inc.
41.08
-4.00%